{"transactions":[{"id":1557771,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIX Common stock Options","published_at":"2024-03-30T01:29:07.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":1.74,"value":174000.0,"ownership":{"direct":true},"balance_after":100000,"derivative":{"exercise_price":1.74,"exercise_date":"2027-03-25","expiration_date":"2034-03-25","underlying":"PTIX Common Stock, Par Value $0.0001","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-24-012069","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315224012069/ownership.xml","form_type":"4"}},{"id":1760737,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIX Common Stock","published_at":"2023-10-13T16:48:45.000Z","date":"2023-10-12","kind":"purchase","planned":false,"acquired":true,"shares":8000,"price":0.81,"value":6480.0,"ownership":{"direct":true},"balance_after":45815,"source":{"system":"sec-edgar","filing":"0001493152-23-037136","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315223037136/ownership.xml","form_type":"4"}},{"id":2266322,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIX Common Stock","published_at":"2022-05-18T21:11:21.000Z","date":"2022-05-18","kind":"purchase","acquired":true,"shares":8000,"price":0.72,"value":5760.0,"ownership":{"direct":true},"balance_after":151260,"source":{"system":"sec-edgar","filing":"0001493152-22-014338","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315222014338/ownership.xml","form_type":"4"}},{"id":2266321,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIX Common Stock","published_at":"2022-05-18T21:11:21.000Z","date":"2022-05-17","kind":"purchase","acquired":true,"shares":23000,"price":0.71,"value":16330.0,"ownership":{"direct":true},"balance_after":143260,"source":{"system":"sec-edgar","filing":"0001493152-22-014338","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315222014338/ownership.xml","form_type":"4"}},{"id":2684261,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIXW Common Stock 5-year warrants strike price $4.98","published_at":"2021-06-03T22:13:18.000Z","date":"2021-06-03","kind":"purchase","acquired":true,"shares":16900,"price":0.38,"value":6422.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":4.98,"exercise_date":"2021-06-03","expiration_date":"2026-04-26","underlying":"PTIX Common Stock","underlying_shares":16900},"source":{"system":"sec-edgar","filing":"0001493152-21-013554","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221013554/ownership.xml","form_type":"4"}},{"id":2684260,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIXW Common Stock 5-year warrants strike price $4.98","published_at":"2021-06-03T22:13:18.000Z","date":"2021-06-02","kind":"purchase","acquired":true,"shares":100,"price":0.38,"value":38.0,"ownership":{"direct":true},"balance_after":33100,"derivative":{"exercise_price":4.98,"exercise_date":"2021-06-02","expiration_date":"2026-04-26","underlying":"PTIX Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001493152-21-013554","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221013554/ownership.xml","form_type":"4"}},{"id":2689654,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIXW Common Stock 5-year warrants strike price $4.98","published_at":"2021-06-01T10:05:16.000Z","date":"2021-05-27","kind":"purchase","acquired":true,"shares":3000,"price":0.38,"value":1140.0,"ownership":{"direct":true},"balance_after":33000,"derivative":{"exercise_price":4.98,"exercise_date":"2021-05-27","expiration_date":"2026-04-26","underlying":"PTIX Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001493152-21-013279","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221013279/ownership.xml","form_type":"4"}},{"id":2703818,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIXW Common Stock 5-year warrants strike price $4.98","published_at":"2021-05-20T20:24:03.000Z","date":"2021-05-18","kind":"purchase","acquired":true,"shares":18000,"price":0.31,"value":5580.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":4.98,"exercise_date":"2021-05-18","expiration_date":"2026-04-26","underlying":"PTIX Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001493152-21-012357","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221012357/ownership.xml","form_type":"4"}},{"id":2703817,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIXW Common Stock 5-year warrants strike price $4.98","published_at":"2021-05-20T20:24:03.000Z","date":"2021-05-18","kind":"purchase","acquired":true,"shares":12000,"price":0.32,"value":3840.0,"ownership":{"direct":true},"balance_after":12000,"derivative":{"exercise_price":4.98,"exercise_date":"2021-05-18","expiration_date":"2026-04-26","underlying":"PTIX Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001493152-21-012357","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221012357/ownership.xml","form_type":"4"}},{"id":2733404,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIX Common Stock","published_at":"2021-05-03T20:15:08.000Z","date":"2021-04-30","kind":"purchase","acquired":true,"shares":1000,"price":2.29,"value":2290.0,"ownership":{"direct":true},"balance_after":120260,"source":{"system":"sec-edgar","filing":"0001493152-21-010335","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221010335/ownership.xml","form_type":"4"}},{"id":2733403,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIX Common Stock","published_at":"2021-05-03T20:15:08.000Z","date":"2021-04-29","kind":"purchase","acquired":true,"shares":1000,"price":2.29,"value":2290.0,"ownership":{"direct":true},"balance_after":119260,"source":{"system":"sec-edgar","filing":"0001493152-21-010335","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221010335/ownership.xml","form_type":"4"}},{"id":3079125,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIX Common stock Options","published_at":"2020-07-21T21:05:52.000Z","date":"2020-07-18","kind":"grant","acquired":true,"shares":124998,"price":1.75,"value":218746.5,"ownership":{"direct":true},"balance_after":124998,"derivative":{"exercise_price":1.75,"exercise_date":"2020-07-18","expiration_date":"2030-07-18","underlying":"PTIX Common Stock, Par Value $0.0001","underlying_shares":124998},"source":{"system":"sec-edgar","filing":"0001493152-20-013712","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315220013712/ownership.xml","form_type":"4"}},{"id":3246915,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIX Common stock Options","published_at":"2020-02-27T01:15:14.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":307497,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"As this was an option grant, there was no cost to the recipient."}],"balance_after":307497,"derivative":{"exercise_price":1.75,"exercise_date":"2023-02-21","expiration_date":"2030-02-21","underlying":"PTIX Common Stock, Par Value $0.0001","underlying_shares":307497},"source":{"system":"sec-edgar","filing":"0001493152-20-003033","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315220003033/ownership.xml","form_type":"4"}},{"id":3580130,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"PTIX Common stock Options","published_at":"2019-03-25T10:10:16.000Z","date":"2019-03-20","kind":"grant","acquired":true,"shares":41667,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":41667,"derivative":{"exercise_price":1,"exercise_date":"2019-03-31","expiration_date":"2029-03-20","underlying":"PTIX","underlying_shares":41667},"source":{"system":"sec-edgar","filing":"0001493152-19-003805","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315219003805/ownership.xml","form_type":"4"}},{"id":4184193,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":92544,"kind":"person","name":"Arrow Alexander K.","position":1,"cik":"0001497166","reported_name":"Arrow Alexander K.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Non-Qualified Stock Options (Right to Buy)","published_at":"2017-10-18T18:46:57.000Z","date":"2017-10-16","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting in equal installments over 36 months, full vesting upon change of control"}],"balance_after":75000,"derivative":{"exercise_price":1.75,"expiration_date":"2027-10-16","underlying":"Protagenic Therapeutics, Inc. Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001437749-17-017238","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000143774917017238/rdgdoc.xml","form_type":"4"}}]}